Literature DB >> 16944024

Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice.

Leo R Fitzpatrick1, Vineeta Khare, Jeffrey S Small, Walter A Koltun.   

Abstract

Low molecular mass polypeptide 2 (LMP2) is an inducible proteasome subunit. Our goals were to examine LMP2 expression in mice with dextran sulfate sodium (DSS)-induced colitis and to evaluate colitis in LMP2 knockout (LMP2-/-) mice. Mice were given 2.5% DSS in the drinking water. On day 0, 2, 4, or 6 after DSS treatment, LMP2 expression was determined in the distal colon by western blot and immunohistochemistry. Parameters of colitis were measured in LMP2-/- mice or wild-type mice. LMP2 expression was enhanced in the colon of DSS-treated mice at all time points. Symptoms of DSS-induced colitis were always lower in LMP2-/- mice. Normalized histology scores and colonic IL-1ss levels increased over the 6-day study period in wild-type mice. These parameters were significantly reduced in LMP2-/- mice that consumed DSS for 6 days. Enhanced LMP2 expression contributes to the pathogenesis of DSS-induced colitis in mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944024     DOI: 10.1007/s10620-006-8047-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Selective proteasome inhibitors: modulators of antigen presentation?

Authors: 
Journal:  Drug Discov Today       Date:  1999-02       Impact factor: 7.851

Review 2.  NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases.

Authors:  C Jobin; R B Sartor
Journal:  Inflamm Bowel Dis       Date:  2000-08       Impact factor: 5.325

3.  Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases.

Authors:  Sílvia Barceló-Batllori; Muriel André; Catherine Servis; Nicole Lévy; Osamu Takikawa; Pierre Michetti; Marc Reymond; Emanuela Felley-Bosco
Journal:  Proteomics       Date:  2002-05       Impact factor: 3.984

4.  In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats.

Authors:  L R Fitzpatrick; J Wang; T Le
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

Review 5.  The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection.

Authors:  C Jobin; R B Sartor
Journal:  Am J Physiol Cell Physiol       Date:  2000-03       Impact factor: 4.249

6.  Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.

Authors:  Karl Egerer; Ulrike Kuckelkorn; Paul E Rudolph; Jens C Rückert; Thomas Dörner; Gerd-R Burmester; Peter-M Kloetzel; Eugen Feist
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

7.  Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats.

Authors:  Leo R Fitzpatrick; Jian Wang; Truc Le
Journal:  Inflamm Bowel Dis       Date:  2002-05       Impact factor: 5.325

8.  Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

Authors:  Shin Maeda; Li-Chung Hsu; Hongjun Liu; Laurie A Bankston; Mitsutoshi Iimura; Martin F Kagnoff; Lars Eckmann; Michael Karin
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

9.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes.

Authors:  M Aki; N Shimbara; M Takashina; K Akiyama; S Kagawa; T Tamura; N Tanahashi; T Yoshimura; K Tanaka; A Ichihara
Journal:  J Biochem       Date:  1994-02       Impact factor: 3.387

10.  Link between organ-specific antigen processing by 20S proteasomes and CD8(+) T cell-mediated autoimmunity.

Authors:  Ulrike Kuckelkorn; Thomas Ruppert; Britta Strehl; Peter R Jungblut; Ursula Zimny-Arndt; Stephanie Lamer; Immo Prinz; Ilse Drung; Peter-M Kloetzel; Stefan H E Kaufmann; Ulrich Steinhoff
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  11 in total

Review 1.  Proteasomes in immune cells: more than peptide producers?

Authors:  Marcus Groettrup; Christopher J Kirk; Michael Basler
Journal:  Nat Rev Immunol       Date:  2009-12-11       Impact factor: 53.106

2.  A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes.

Authors:  Kimberly Cornish Carmony; Do-Min Lee; Ying Wu; Na-Ra Lee; Marie Wehenkel; Jason Lee; Beilei Lei; Chang-Guo Zhan; Kyung-Bo Kim
Journal:  Bioorg Med Chem       Date:  2011-07-07       Impact factor: 3.641

3.  Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome.

Authors:  Michael Basler; Elmer Maurits; Gerjan de Bruin; Julia Koerner; Herman S Overkleeft; Marcus Groettrup
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

Review 4.  Activity-based imaging probes of the proteasome.

Authors:  Kimberly Cornish Carmony; Kyung Bo Kim
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

Review 5.  Inhibitors of the immunoproteasome: current status and future directions.

Authors:  Zachary Miller; Lin Ao; Kyung Bo Kim; Wooin Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis.

Authors:  Leo R Fitzpatrick
Journal:  Int J Inflam       Date:  2012-03-15

7.  Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.

Authors:  Michael Basler; Sarah Mundt; Tony Muchamuel; Carlo Moll; Jing Jiang; Marcus Groettrup; Christopher J Kirk
Journal:  EMBO Mol Med       Date:  2014-01-16       Impact factor: 12.137

8.  Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease.

Authors:  Alexander Visekruna; Nadia Slavova; Sonja Dullat; Jörn Gröne; Anton-Josef Kroesen; Jörg-Peter Ritz; Heinz-Johannes Buhr; Ulrich Steinhoff
Journal:  Int J Colorectal Dis       Date:  2009-03-10       Impact factor: 2.571

9.  Overexpression of CD97 in intestinal epithelial cells of transgenic mice attenuates colitis by strengthening adherens junctions.

Authors:  Susann Becker; Elke Wandel; Manja Wobus; Rick Schneider; Salah Amasheh; Doreen Sittig; Christiane Kerner; Ronald Naumann; Joerg Hamann; Gabriela Aust
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

10.  Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression.

Authors:  Wendy Rodenburg; Jaap Keijer; Evelien Kramer; Carolien Vink; Roelof van der Meer; Ingeborg M J Bovee-Oudenhoven
Journal:  BMC Genomics       Date:  2008-03-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.